• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜酸粒细胞计数预测经皮冠状动脉介入治疗后的死亡率。

Eosinophil count predicts mortality following percutaneous coronary intervention.

机构信息

Department of Cardiology, City Hospital, Birmingham B18 7QH, UK.

出版信息

Thromb Res. 2012 Oct;130(4):607-11. doi: 10.1016/j.thromres.2012.05.033. Epub 2012 Jul 6.

DOI:10.1016/j.thromres.2012.05.033
PMID:22771073
Abstract

INTRODUCTION

Several inflammatory markers have been shown to be independent predictors for both the development of clinically significant atherosclerosis and for adverse outcome in patients with symptomatic coronary artery disease (CAD). We investigated the prognostic role of eosinophil count in low to intermediate risk patients with CAD.

METHODS

We studied 909 patients admitted for elective or urgent percutaneous coronary intervention (PCI) from April 2002 to December 2004, and measured pre-procedural total and differential white blood cell (WBC) counts. Inter-tertile WBC differences in short (6months) and long term (up to 74months) mortality were analysed after adjusting for differences in baseline characteristics.

RESULTS

Over a median period of 54months (inter-quartile range 47-65), a total of 138 deaths (15.2%) occurred, of which 24 were in the first 6months of follow-up. Cox regression analysis showed that high pre-procedural eosinophil count (top tertile) was associated with improved outcome within the first 6months (OR=0.23 [0.06-0.84]; p=0.03) but after this period there was an increased risk of mortality (OR=2.21, [1.26-3.88]; p=0.006).

CONCLUSIONS

Eosinophil count is a novel biomarker for risk stratification of CAD patients, which was associated initially with reduced mortality, but after 6months with increased mortality.

摘要

简介

多项炎症标志物已被证明是有症状的冠心病(CAD)患者发生临床显著动脉粥样硬化和不良预后的独立预测因子。我们研究了嗜酸性粒细胞计数在 CAD 低至中危患者中的预后作用。

方法

我们研究了 2002 年 4 月至 2004 年 12 月期间因选择性或紧急经皮冠状动脉介入治疗(PCI)入院的 909 例患者,并测量了术前总白细胞计数和白细胞分类计数。在调整基线特征差异后,分析了短期(6 个月)和长期(长达 74 个月)死亡率的白细胞差异。

结果

在中位数为 54 个月(四分位距 47-65)的期间内,共有 138 例死亡(15.2%),其中 24 例发生在随访的前 6 个月内。Cox 回归分析显示,高术前嗜酸性粒细胞计数(最高三分位)与前 6 个月内的改善结果相关(OR=0.23 [0.06-0.84];p=0.03),但在此期间,死亡率的风险增加(OR=2.21,[1.26-3.88];p=0.006)。

结论

嗜酸性粒细胞计数是 CAD 患者风险分层的一种新的生物标志物,最初与死亡率降低相关,但 6 个月后与死亡率增加相关。

相似文献

1
Eosinophil count predicts mortality following percutaneous coronary intervention.嗜酸粒细胞计数预测经皮冠状动脉介入治疗后的死亡率。
Thromb Res. 2012 Oct;130(4):607-11. doi: 10.1016/j.thromres.2012.05.033. Epub 2012 Jul 6.
2
Preprocedural white blood cell count as a predictor of death and major adverse cardiac events in patients undergoing percutaneous coronary intervention with drug-eluting stents.术前白细胞计数作为接受药物洗脱支架经皮冠状动脉介入治疗患者死亡和主要不良心脏事件的预测指标。
J Invasive Cardiol. 2009 May;21(5):202-6.
3
Preprocedural white blood cell count and death after percutaneous coronary intervention.经皮冠状动脉介入治疗前白细胞计数与死亡情况
Am Heart J. 2003 Oct;146(4):692-8. doi: 10.1016/S0002-8703(03)00230-8.
4
Favorable long-term survival in patients undergoing stent PCI of unprotected left main coronary artery compared to predicted short-term prognosis of CABG estimated by EuroSCORE: clinical determinants of long-term outcome.与EuroSCORE 预测的 CABG 短期预后相比,接受无保护左主干冠状动脉支架 PCI 的患者具有良好的长期生存:长期结果的临床决定因素。
J Interv Cardiol. 2009 Aug;22(4):311-9. doi: 10.1111/j.1540-8183.2009.00480.x.
5
Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients.经皮冠状动脉介入治疗后围手术期心肌坏死对预后的意义:5487 例患者介入前后肌钙蛋白 T 水平分析。
Circ Cardiovasc Interv. 2008 Aug;1(1):10-9. doi: 10.1161/CIRCINTERVENTIONS.108.765610.
6
Preprocedural neutrophil count predicts outcome in patients with advanced peripheral vascular disease undergoing percutaneous transluminal angioplasty.术前中性粒细胞计数可预测接受经皮腔内血管成形术的晚期外周血管疾病患者的预后。
J Vasc Surg. 2008 Dec;48(6):1504-8. doi: 10.1016/j.jvs.2008.07.072.
7
Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.肾功能不全严重程度对行经皮冠状动脉介入治疗患者住院死亡率相关因素的影响。
Catheter Cardiovasc Interv. 2012 Sep 1;80(3):352-7. doi: 10.1002/ccd.23394. Epub 2012 May 4.
8
Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.慢性肾脏病患者多支冠状动脉疾病行冠状动脉旁路移植术或药物洗脱支架植入术的短期和长期预后
Am J Cardiol. 2010 Aug 1;106(3):348-53. doi: 10.1016/j.amjcard.2010.03.037. Epub 2010 Jun 18.
9
White blood cell count adds prognostic information to the thrombolysis in myocardial infarction risk index in patients following primary percutaneous coronary intervention (ANIN Myocardial Infarction Registry).在接受直接经皮冠状动脉介入治疗的患者中,白细胞计数为心肌梗死溶栓风险指数增添了预后信息(ANIN心肌梗死注册研究)。
Int J Cardiol. 2007 Apr 4;116(3):376-82. doi: 10.1016/j.ijcard.2006.03.061. Epub 2006 Aug 1.
10
Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts.术前白细胞计数与隐静脉移植血管经皮冠状动脉介入治疗术后晚期主要不良心脏事件
Am J Cardiol. 2005 Aug 15;96(4):515-8. doi: 10.1016/j.amjcard.2005.03.103.

引用本文的文献

1
Blood eosinophil count is associated with early atherosclerotic artery changes in asthma.血液嗜酸性粒细胞计数与哮喘的早期动脉粥样硬化性动脉变化有关。
BMC Pulm Med. 2024 Oct 11;24(1):509. doi: 10.1186/s12890-024-03322-0.
2
Differential roles of eosinophils in cardiovascular disease.嗜酸性粒细胞在心血管疾病中的不同作用。
Nat Rev Cardiol. 2025 Mar;22(3):165-182. doi: 10.1038/s41569-024-01071-5. Epub 2024 Sep 16.
3
Prediction of Osteoporotic Hip Fracture Outcome: Comparative Accuracy of 27 Immune-Inflammatory-Metabolic Markers and Related Conceptual Issues.
骨质疏松性髋部骨折结局的预测:27种免疫炎症代谢标志物的比较准确性及相关概念问题
J Clin Med. 2024 Jul 7;13(13):3969. doi: 10.3390/jcm13133969.
4
Value of Absolute Eosinophil Count in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者中嗜酸性粒细胞绝对计数的价值
Int J Gen Med. 2024 Mar 18;17:1025-1038. doi: 10.2147/IJGM.S451900. eCollection 2024.
5
Predictive value of combining leucocyte and platelet counts for mortality in ST-segment elevation myocardial infarction patients after percutaneous coronary intervention treatment in Chinese population: a retrospective cohort study.联合白细胞和血小板计数对中国人群经皮冠状动脉介入治疗后 ST 段抬高型心肌梗死患者死亡率的预测价值:一项回顾性队列研究。
BMJ Open. 2023 Jul 18;13(7):e060756. doi: 10.1136/bmjopen-2022-060756.
6
The Predictive Values of White Blood Cell Indices (Lymphocyte and Eosinophilic Granulocyte) for Heart Failure in Acute Coronary Syndrome Patients Following Percutaneous Coronary Intervention: A Prospective Cohort Study.白细胞指标(淋巴细胞和嗜酸性粒细胞)对经皮冠状动脉介入治疗后急性冠状动脉综合征患者心力衰竭的预测价值:一项前瞻性队列研究。
Clin Interv Aging. 2023 Jun 17;18:951-962. doi: 10.2147/CIA.S413313. eCollection 2023.
7
Rethinking blood eosinophil counts: Epidemiology, associated chronic diseases, and increased risks of cardiovascular disease.重新审视血液嗜酸性粒细胞计数:流行病学、相关慢性疾病及心血管疾病风险增加
J Allergy Clin Immunol Glob. 2022 Nov;1(4):233-240. doi: 10.1016/j.jacig.2022.09.001. Epub 2022 Sep 12.
8
Eosinophil percentage as a new prognostic marker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.嗜酸性粒细胞百分比作为接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的一种新的预后标志物。
Interv Med Appl Sci. 2019 Oct 7;11(3):146-153. doi: 10.1556/1646.11.2019.17. eCollection 2020 Sep.
9
The predictive value of eosinophil levels on no-reflow in patients with STEMI following PCI: a retrospective cohort study.经皮冠状动脉介入治疗(PCI)后 ST 段抬高型心肌梗死(STEMI)患者中性粒细胞计数对无复流的预测价值:一项回顾性队列研究。
Sci Rep. 2022 Oct 25;12(1):17862. doi: 10.1038/s41598-022-22988-2.
10
Arterial and venous thromboembolism risk associated with blood eosinophils: A systematic review and meta-analysis.动脉和静脉血栓栓塞风险与血液嗜酸性粒细胞的关系:系统评价和荟萃分析。
Animal Model Exp Med. 2022 Oct;5(5):470-481. doi: 10.1002/ame2.12277. Epub 2022 Oct 7.